Similar articles

• Association of Endogenous Endophthalmitis With Intravenous Drug Use: An Emerging Public Health Challenge.

  Modjtahedi BS, Finn AP, Eliott D. Modjtahedi BS, et al. JAMA Ophthalmol. 2017 Dec 1;135(12):1457. doi: 10.1001/jamaophthalmol.2017.4342. JAMA Ophthalmol. 2017. PMID: 29049453 No abstract available.
• Endogenous Aspergillus endophthalmitis in a healthy individual.

  Mamandhar A, Bajracharya L. Mamandhar A, et al. Nepal J Ophthalmol. 2012 Jan-Jun;4(1):179-83. doi: 10.3126/nepjoph.v4i1.5873. Nepal J Ophthalmol. 2012. PMID: 22344019
• Endogenous Fungal Endophthalmitis: An Increasing Problem Among Intravenous Drug Users.

  Relhan N, Schwartz SG, Flynn HW Jr. Relhan N, et al. JAMA. 2017 Aug 22;318(8):741-742. doi: 10.1001/jama.2017.10585. JAMA. 2017. PMID: 28829854 No abstract available.
• Endogenous endophthalmitis with azole-resistant Candida albicans--Case report and review of the literature.

  Osthoff M, Hilge R, Schulze-Döbold C, Bogner JR. Osthoff M, et al. Infection. 2006 Oct;34(5):285-8. doi: 10.1007/s15010-006-5119-3. Infection. 2006. PMID: 17033755 Review.
• Endogenous endophthalmitis due to Fusarium: case report and review.

  Louie T, el Baba F, Shulman M, Jimenez-Lucho V. Louie T, et al. Clin Infect Dis. 1994 Apr;18(4):585-8. doi: 10.1093/clinids/18.4.585. Clin Infect Dis. 1994. PMID: 8038313 Review.